SCHEMBL1663782

SCHEMBL1663782

O=C(OCCCCCc1ccccc1)C1C2CCC(C3OC23)C1C(=O)OCCCCCc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FKBP1A P62942 3/20 0.47
NAAA Q02083 3/20 0.46
LMNA P02545 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1663378 0.92 NAAA (0.46) FKBP1ANAAALMNA
SCHEMBL2032601 0.84 NAAA (0.50) FKBP1ANAAALMNA
SCHEMBL1663781 0.81 TSHR (0.51) FKBP1A
SCHEMBL28457843 0.79 FKBP1A (0.54) FKBP1ANAAALMNA
SCHEMBL1664583 0.77 NAAA (0.51) FKBP1ANAAALMNA
SCHEMBL27176007 0.77 FKBP1A (0.58) FKBP1ANAAALMNA
SCHEMBL11607831 0.76 PPARG (0.45) NAAA
SCHEMBL19512246 0.76 FKBP1A (0.51) FKBP1ANAAALMNA
SCHEMBL1664418 0.76 NAAA (0.44) NAAA
SCHEMBL1665164 0.75 NAAA (0.48) NAAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011071674-A1 ASYMMETRIC CYCLIC DIESTER COMPOUNDS FERRO CORPORATION (US) 2011-06-16 WO disclosed
EP-2307476-A1 ASYMMETRIC CYCLIC DIESTER COMPOUNDS FERRO CORPORATION (US) 2011-04-13 EP disclosed
US-20100113664-A1 Asymmetric Cyclic Diester Compounds FERRO CORPORATION (US) 2010-05-06 US disclosed
WO-2009152068-A1 ASYMMETRIC CYCLIC DIESTER COMPOUNDS FERRO CORPORATION (US) 2009-12-17 WO disclosed
US-20090312470-A1 Asymmetric Cyclic Diester Compounds FERRO CORPORATION (US) 2009-12-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090312470-A1 Asymmetric Cyclic Diester Compounds DDT, PCNA, AADAC FKBP1A 666/4885NAAA 509/4885LMNA 3399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.